This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
The AHFS DI is one of several compendiums[1] approved by the Social Security Act (Section 1861(t)(2)(B)(ii)(I)) as a source of off-label anti-cancer drug use.[2][3] It was originally published in 1959 as the American Hospital Formulary Service (AHFS) by the American Society of Health-System Pharmacists.
It is also the only one left of the originally authorized compendiums.[4]
References
edit- ^ ElizabethHalpern, Hogan Lovells-; Langbein, Stuart M.; Manning, Meredith; Roberts, Beth L.; Lakhani, Ali (14 August 2015). "And then there were five: CMS approves Wolters Kluwer Lexi-Drugs® as the fifth recognized authoritative compendium | Lexology". Retrieved 2018-03-30.
- ^ "Medical Coverage Document". Centers for Medicare & Medicaid Services. cms.gov. Retrieved 6 January 2018.
- ^ Abernethy, Amy (October 2012). "Role of Compendia in Determining what Drugs are Reimbursed". National Science Foundation.
- ^ Butcher, Lola (2008-06-25). "Compendia Decisions Impact Off-Label Coverage". Oncology Times. 30 (12): 29–30. doi:10.1097/01.COT.0000326167.89228.b6. ISSN 0276-2234.
Further reading
edit- "Gain a solid understanding of compendia and its impact on patient access". Formulary Journal. 2012-07-01. Retrieved 2018-03-30.
External links
edit
 | This article about a medical book is a stub. You can help Wikipedia by expanding it. |